ReviewInternational journal of molecular sciences2025

30 Years Since the Proposal of Exon Skipping Therapy for Duchenne Muscular Dystrophy and the Future of Pseudoexon Skipping.

Masafumi MatsuoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.